MRI-based mathematical modeling to predict the response of cervical cancer patients to chemoradiation
Patients with locally advanced cervical cancer have a 20–30% risk of residual disease after completion of standard-of-care chemoradiation. A reliable and patient-specific method to predict treatment response is currently lacking but would be valuable for selecting therapeutic regimens with improved outcomes. We developed an MRI-based mathematical model for tumor cell movement, proliferation, and response to chemoradiation. The model was calibrated for each patient using their own MRI data before (V1) and after two weeks (V2) of chemoradiation. In the study cohort of 10 patients, the concordance correlation coefficients between the observed and predicted changes in tumor cellularity and volume from V1 to V3 (after five weeks of chemoradiation) were 0.96 and 0.78, respectively. Thus, our model can accurately predict response to chemoradiation for cervical cancer patients using each patient’s MRI data, thereby offering potential for personalizing chemoradiation regimens during treatment.
Authors
- Gaiane Margishvili Rauch (ORCID: https://orcid.org/0000-0003-2079-5202)
- Rania M. M. Mohamed (ORCID: https://orcid.org/0000-0002-6487-3965)
- Reshmi J. S. Patel (ORCID: https://orcid.org/0000-0002-6813-3091)
- David A. Hormuth (ORCID: https://orcid.org/0000-0002-9643-1694)
- Casey E. Stowers (ORCID: https://orcid.org/0000-0002-7157-6248)
- Thomas E. Yankeelov (ORCID: https://orcid.org/0000-0002-7022-0565)
- Chitraksh Pandey (ORCID: https://orcid.org/0009-0005-4413-1584)
- Chengyue Wu
- Jingfei Ma
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- The University of Texas at Austin (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- npj Women s Health
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1038/s44294-026-00169-0
- Primary Topic
- Mathematical Biology Tumor Growth
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- Cancer Prevention and Research Institute of Texas
- University of Texas at Austin
- National Institutes of Health
- University of Texas MD Anderson Cancer Center